Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Survey to Check Who May Join Future Psychiatry Studies

A survey asks adults with depression, anxiety or borderline personality disorder about study eligibility.

Plain-language title generated from the registry record
Registry title: Triage Survey for Psychiatry Research Eligibility

Key facts

Where
Boston, DeSoto, New York, Philadelphia, The Bronx, and Watertown, United StatesSee the 6 sites

Where in United States

  • Adams Clinical BostonBoston, United StatesTaking people
  • Adams Clinical DallasDeSoto, United StatesTaking people
  • Adams Clinical HarlemNew York, United StatesTaking people
  • Adams Clinical PhiladelphiaPhiladelphia, United StatesTaking people
  • Adams Clinical BronxThe Bronx, United StatesTaking people
  • Adams Clinical WatertownWatertown, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Adams Clinical
Trial code
NCT05800925
Record updated
20 May 2026
Original description
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.Read full original descriptionShow less

Triage Survey for Psychiatry Research Eligibility

TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

Inclusion: Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed; Participant is at least 18 years old.

Exclusion: Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant; History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results; Any condition that in the investigator's opinion makes a participant unsuitable for the study; Participant is pregnant, breast-feeding, or planning to become pregnant; Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening; Currently employed by Adams Clinical or a first-degree relative of an employee.

ClinicalTrials.gov NCT05800925